Company Filing History:
Years Active: 2023
Title: Eric Armentani: Innovator in Modified IL-2 Polypeptides
Introduction
Eric Armentani is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of biotechnology, particularly in the development of modified IL-2 polypeptides. His work focuses on innovative treatments for diseases, including cancer.
Latest Patents
Eric Armentani holds a patent for "Modified IL-2 polypeptides and uses thereof." This patent encompasses modified IL-2 polypeptides, compositions that include these polypeptides, methods for their production, and their application in treating various diseases. Notably, the patent highlights the use of these modified IL-2 polypeptides in cancer treatment. The disclosed IL-2 polypeptides demonstrate preferential binding to the IL-2 receptor βγ complex over the IL-2 receptor αβγ complex. Additionally, the molecular weight distribution of these polypeptides is characterized as monodispersed. He has 1 patent to his name.
Career Highlights
Eric Armentani is currently associated with Bright Peak Therapeutics AG, where he continues to advance his research and development efforts. His work is pivotal in the ongoing quest for effective cancer therapies.
Collaborations
Eric collaborates with esteemed colleagues, including Vijaya Raghavan Pattabiraman and Roberto Iacone, who contribute to his innovative projects and research initiatives.
Conclusion
Eric Armentani's contributions to the field of biotechnology, particularly through his patent on modified IL-2 polypeptides, underscore his role as a key innovator in developing new treatments for cancer. His work continues to inspire advancements in medical science.